On being a good doctor. The number of research publications don’t tell you how good a doctor is at being a doctor. Neither do the number of book chapters or grants. Or academic rank. It’s a different skill set. Good doctors have stellar clinical acumen & empathy. #MedTwitter

The pathological classification of vasculitic neuropathy, categorized by vessel size, divides it into nerve microvasculitis and nerve large arteriole vasculitis. Despite its decades of use, the clinical significance of this classification has not been thoroughly assessed. In

Interpreting nerve conduction studies can be challenging due to numerous confounding factors, particularly in the lower limbs. These can include aging, the frequency of L5-S1 radiculopathies, and repetitive trauma to the feet. The upper extremity studies are less prone to

Good morning, #NeuroX; I hope you all are having a great week in the clinic and will not feel down learning that Dr. Peter Dyck could identify the etiology of 76% of the “idiopathic” neuropathies referred to him in the 1970s. In this post, I break down one of my favorite papers

I often remind our Mayo Clinic Neuro trainees that Charcot-Marie-Tooth disease (CMT) is primarily a clinical diagnosis. Family history is important, but if the neuropathy is slowly progressive, painless, predominantly motor, and the patient has bilateral foot drop, muscle atrophy,

Hot off the press 🔥Our review article on Atypical Clinicopathological Manifestations of #IMNM #NAM. sciencedirect.com/science/articl… Time is Muscle 💪!!! Recognizing these atypical features helps expedite #Diagnosis and promptly initiate treatments. #Myositis

Thank you, Mayo Fellows' Association, Rochester, for a wonderful night celebrating the Mayo Clinic 2025 Educator Awards. A special thanks to Mayo Clinic Neurology Residency and Mayo Clinic Neurology Fellowships, especially #JonLang (PGY-3) for the heartfelt speech and for presenting me with the award. I am incredibly grateful 🥹.

A common misconception regarding the treatment of Guillain-Barré syndrome (GBS) is the idea that it can be categorized as either "IVIg responsive" or "resistant." The only two therapies that are effective for GBS—plasma exchange and intravenous immunoglobulin (IVIg)—do not change

Mayo Clinic Neuro honor and celebrate the life of Prof. Andrew G. Engel, one of the founding fathers of #myology. His legacy lives on in every patient we care for and in every muscle biopsy we examine. His life’s work continues to guide, inspire, & shape the field he helped build.

I need to find a special portrait for this one. On January 20, 2025, we gathered at the Mayo Clinic Foundation House to honor Prof. Peter J. Dyck’s retirement and distinguished and unparalleled career. The photo is signed by him 🥹. Beyond grateful for this wonderful gift.

Toxic neuropathies that may present like GBS: 🔺Hexane (glue-sniffing) 🔺Thalium 🔺Arsenic 🔺Lead 🔺 ICI 🔺Ciguatoxin 🔺Vincristine 🔺Calcineurin inhibitors 🔺 Immune check-point inhibitors 🔺 Organophosphates 🔺 Diethylene glycol When heavy metals intoxication cause a

Dear Neurology Residents Starting in the ED Next Month, You will frequently encounter “?GBS” or “GBS rule out” consults. Please remember to carry your reflex hammer, save this post for future reference, and read the open-access review that I share ⬇️. 🤓 Since you won’t have

Elie Naddaf, look at our vasculitic myopathy cover being highlighted again. We were already grateful to be featured at the Neurology Journal booth during the 2025 AANAM (photo ⬇️). 🤩 Thank you once again, Neurology Journal! The most clinically relevant neurology journal worldwide.

Continuing the series of posts highlighting Dr. Dyck’s legendary career, I focus today on two seminal papers by Drs. Dyck and Lambert that laid the foundation for the modern classification of Charcot-Marie-Tooth disease (CMT) types 1, 2, 3 (formerly known as Dejerine-Sottas

Dr. Peter J. Dyck passed away peacefully surrounded by family on 07/26/25 at the age of 97. We will honor his legacy and keep him alive through our research, teachings, and patient care. Rest in peace and thank you for everything, Peter! Mayo Clinic Neuro

Neurodiab created this excellent summary of Dr. Dyck’s Neurology Journal seminal manuscript on the epidemiology of diabetic neuropathy. Their youth committee connected with Dr. Dyck a few months ago, and he wrote a comment about the study. Thank you for doing this, Neurodiab!

💪 Exercise & Neuromuscular Diseases: Busting Myths & Sharing Tips 🧵 1️⃣ Myth: “Exercise will destroy your muscles.” 🚫 Wrong! Across acquired & inherited neuromuscular disorders, studies show no harm—and often real benefits. 2️⃣ Strength matters. Weights, bands, cables—anything

Monoclonal gammopathy–associated myopathies are rare but treatable myopathies. There are four subtypes: AL amyloid myopathy, Sporadic late onset nemaline myopathy, scleromyxedema, and glycogen storage myopathy. Check out our review lead by Teerin Liewluck, MD, FAAN, FANA Neurology Journal.